Pharmaceutical Executive-09-01-2008

Pharm Exec's 7th annual review of the top companies. We slice and dice the numbers to see who's the best a what. (pdf)

Effective January 1st, sales reps will have a new standard for dealing with doctors the PhRMA way

FDAAA means that you need to register clinical trials-and not only for publication planning

Outsourcing saves money-except when it doesn't. Here's how to decide what to do.

FDA missteps and global outsourcing are drawing Congressional scrutiny and prompting new oversight approaches

Leaders don't always manage to do the right thing, but they constantly strive to access the wellspring of integrity within them

Young & Partners crunches pharma's filings for, the first half of '08. The results? Ask the Japanese

The smart way to CRM is through SaaS

The United States makes the best medicines in the world. In days to come, that could be a problem.

Concerns over quality? It's not stopping Big Pharma outsourcing and venture capital.

The industry is a-changing. Here are eight seminal events that describe how.

The Orphan Drug Act was passed 25 years ago. But the challenge of actually getting rare disease drugs and therapies to patients still remains

How will pharma fare in the new age of health and wellness marketing?

In order to take a big step forward, GSK looks to employ smaller licensing deals and business units